Company Profile
CEO
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.(CEO & Executive Director)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
96.1K
Beta
0.21
Forward P/E
23.2
52W High
$212.71
52W Low
$137.22
Profit Margin
17.2%
Operating Margin
27.9%
Return on Equity
23.5%
Revenue Growth
12.5%
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Ongl...
Valuation
Market Cap$281.75B
P/E (TTM)43.18
P/S (TTM)4.87
EV/EBITDA--
Cash Flow
FCF Yield--
SBC Adj. FCF Yield--
SBC Impact--
Margins & Growth
Profit Margin16.9%
Operating Margin24.3%
Revenue YoY12.5%
Earnings YoY5.6%
Balance
Cash--
Debt--
Net Cash--
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--